Monoclonal antibodies reduce RSV-related hospitalizations in premature infants with nirsevimab showing highest SUCRA values
Monoclonal antibodies reduce hospital stays for babies with RSV
This systematic review and network meta-analysis evaluated monoclonal antibodies for respiratory syncytial virus disease in premature infant…
Three different monoclonal antibodies all reduced the risk of hospitalization for premature infants with RSV infections, with one showing th…
RSV infection complicated by acute otitis media in 27.7% of children under 5
RSV infection often leads to middle ear infections in children
This meta-analysis of children aged 0-60 months found that 27.7% of RSV infections are complicated by acute otitis media (AOM), and RSV is d…
Nearly 28% of children with RSV infections develop a middle ear infection, which is often complicated by bacterial growth.
Nirsevimab and maternal RSVpreF vaccination show approximately 80% effectiveness against RSV-associated hospitalization in children
Nirsevimab and Maternal Vaccination Show Promise for RSV Protection
This meta-analysis of 43 observational studies evaluates nirsevimab and maternal RSVpreF vaccination for preventing RSV-associated hospitali…
New data suggests that nirsevimab and maternal vaccination may significantly reduce hospitalizations caused by the respiratory syncytial vir…
GSK investigational MMRV vaccine shows comparable immunogenicity to licensed MMRV in healthy children
GSK MMRV vaccine shows comparable safety and immune response to licensed MMRV in young children
This randomized, multi-country phase II trial in 801 healthy children aged 4-6 years found that one dose of a GSK investigational MMRV vacci…
A Phase II trial in healthy children found the investigational GSK MMRV vaccine produced immune responses and safety similar to the licensed…
Review of antibody-based strategies against RSV and SARS-CoV-2 in infants
New antibody treatments for babies lower virus hospitalization risk greatly
This narrative review examines antibody-based strategies against respiratory syncytial virus and SARS-CoV-2 in infants. It reports that nirs…
A review of antibody treatments for babies shows they greatly lower hospitalization risk from respiratory viruses. These medicines stay effe…
Hospitalized children with HMPV infection had 28.0% severe CAP rates and higher risks of wheezing and co-infection
Premature birth and wheezing raise severe HMPV pneumonia risk
This retrospective cohort study examined 878 hospitalized children with human metapneumovirus (HMPV)-positive community-acquired pneumonia (…
A study of 878 children finds premature birth and wheezing are strong predictors of severe HMPV pneumonia.
Coadministration of RSV mRNA vaccine and high-dose flu vaccine noninferior for flu but not for RSV in older adults
New data shows RSV and flu shots work well together
This phase 3 randomized controlled trial in 1900 adults aged 65 and older compared coadministration of mRNA-1345 and quadrivalent influenza …
Older adults can now get their RSV and flu vaccines during one visit without safety risks or extra trips to the clinic for care.
Survey finds physicians show stronger intergroup bias than public on vaccines
Doctors Show Strong Bias Against Vaccine-Hesitant Patients
This review of an online survey in Japan involving 492 physicians and 5,252 members of the general public found that physicians exhibited hi…
Doctors often see themselves as targets of vaccine anger, but new data shows they also hold strong bias against patients who question vaccin…
Narrative review on pediatric RSV co-infections and post-pandemic rebound
RSV Hits Kids Harder When Another Bug Joins In
This narrative review synthesizes evidence on pediatric RSV co-infections in a global context.
It started with a sniffle. Then a cough. By day three, 7-month-old Mia was breathing fast, ribs pulling in with each breath.
Infection status associated with hypoxemia and death rates varying by virus type in a large US cohort
Triple Virus Infections Rarer Than Feared — Here’s the Real Risk
This cohort study of 835,987 triple-tested patients in the US Veterans Health Administration examined associations between infection status …
It’s winter. Your throat is scratchy. Your chest feels tight.
Adjuvanted RSV vaccine shows efficacy against RSV disease in older adults with comorbidities
One RSV Shot Protects High-Risk Older Adults for Three Full Seasons
This post-hoc analysis of a phase 3 trial evaluated an adjuvanted RSVPreF3 dose in medically stable adults aged 60 and older with underlying…
One RSV shot cuts illness risk by 63% to 75% for older adults with COPD, asthma, diabetes, or obesity over three full seasons.
Methodological review assesses phenotypes for classifying respiratory viruses in English health data
How Doctors Track RSV, Flu, and COVID When Tests Aren't Always Done
This methodological review evaluates phenotypes for classifying respiratory viruses like RSV, influenza, and COVID-19 in English coded healt…
Coded health records can now identify RSV, flu, and COVID-19 outbreaks without lab tests, helping public health agencies track disease trend…
Questions about Human Metapneumovirus Infection
What specific risks are associated with Human Metapneumovirus Infection in hospitalized children?
Hospitalized children with Human Metapneumovirus (HMPV) face high risks of severe pneumonia, wheezing, and co-infections, with infants and those with underlying health issues being most vulnerable.
Full answer →All Human Metapneumovirus Infection Articles
- Monoclonal antibodies reduce RSV-related hospitalizations in premature infants with nirsevimab showing highest SUCRA values
- RSV infection complicated by acute otitis media in 27.7% of children under 5
- Nirsevimab and maternal RSVpreF vaccination show approximately 80% effectiveness against RSV-associated hospitalization in children
- GSK investigational MMRV vaccine shows comparable immunogenicity to licensed MMRV in healthy children
- Review of antibody-based strategies against RSV and SARS-CoV-2 in infants
- Hospitalized children with HMPV infection had 28.0% severe CAP rates and higher risks of wheezing and co-infection
- Coadministration of RSV mRNA vaccine and high-dose flu vaccine noninferior for flu but not for RSV in older adults
- Survey finds physicians show stronger intergroup bias than public on vaccines
- Narrative review on pediatric RSV co-infections and post-pandemic rebound
- Infection status associated with hypoxemia and death rates varying by virus type in a large US cohort
- Methodological review assesses phenotypes for classifying respiratory viruses in English health data
- Adjuvanted RSV vaccine shows efficacy against RSV disease in older adults with comorbidities
- Measles incidence increased in Galmudug State, Somalia, from 2023 to 2024
- Meta-analysis finds RSV outcomes peak in early infancy in low- and middle-income countries
- ARTIC-based amplicon sequencing assay evaluated for respiratory syncytial virus detection accuracy and lineage identification
- Night-light intensity and temporal factors associated with increased measles incidence in Ethiopia
- Mass vaccination campaign conducted among Afghan evacuees in US after measles cases
- Field report describes measles response effort among Afghan evacuees at New Jersey base
- Field report describes measles outbreak in central Ohio community
- WHO and CDC report updates on global measles cases and vaccination coverage trends
- US adult vaccination coverage for influenza, COVID-19, and RSV reported in observational data
- Report examines vaccination coverage for influenza, RSV, and COVID-19 in US nursing home residents
- Report describes worldwide progress toward regional measles elimination goals
- WHO African Region progress toward measles elimination assessed from 2017 to 2021
- RSV disease severity compared to COVID-19 and influenza in hospitalized older adults
- Human metapneumovirus and respiratory syncytial virus co-circulation described in US
- Report describes progress toward global measles elimination in worldwide population
- Community cohort study examines symptomatic human metapneumovirus infection incidence
- Suspected measles case reported in unvaccinated child in Clark County, Washington
- Measles vaccine coverage increased in Eastern Mediterranean children but remains below elimination target
- Field report describes nirsevimab rollout for RSV prevention in New York City infants
- Measles outbreak reported among unvaccinated children in Illinois apartment complex
- CDC surveillance report details measles cases from 25 U.S. jurisdictions
- Measles outbreak reported among individuals associated with a Chicago migrant shelter
- RSV vaccine safety findings reported one year after recommendation for adults 60 and older
- Measles outbreak reported in New Mexico, details on population and interventions not provided
- Measles outbreak in Colorado linked to exposure from an infectious international traveler
- PRIORIX vaccine recommended for measles, mumps, and rubella protection in the United States
- Symptom clusters from participatory surveillance data align with specific respiratory pathogens in Dutch and Italian cohorts
- ACIP recommends RSV vaccination for adults 60 years and older in the United States
- ACIP Recommends Nirsevimab for Severe RSV Prevention in Infants and Young Children
- RSV Immunization Coverage Among US Infants Receiving Nirsevimab or Maternal Vaccination
- CDC recommends clesrovimab for preventing severe RSV lower respiratory infections in infants
- Palivizumab reduces medically attended RSV infections in preterm infants, shows similar efficacy to nirsevimab
- Case report: Initial positive measles IgM tests in two Samoan children were false positives